Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,206 | 58,539 | 64,297 | 10,209 | 15,846 |
| TOTAL | $51,904 | $61,529 | $66,322 | $12,236 | $18,086 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $51,904 | $61,529 | $66,322 | $12,236 | $18,086 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 779 | 568 | 524 | 887 | 927 |
| Accrued Expenses | 2,195 | 1,303 | 710 | 806 | 890 |
| TOTAL | $2,974 | $1,871 | $1,234 | $1,693 | $1,817 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 27,737 | 27,392 |
| TOTAL | $N/A | $N/A | $N/A | $27,737 | $27,392 |
| Total Liabilities | $2,974 | $1,871 | $1,234 | $29,430 | $29,209 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,362 | 37,362 | 37,352 | 37,352 | 10,000 |
| Common Shares | 4 | 4 | 4 | 1 | 1 |
| Retained earnings | -46,748 | -35,776 | -30,092 | -24,700 | -14,362 |
| TOTAL | $48,930 | $59,658 | $65,088 | $-17,194 | $-11,123 |
| Total Liabilities And Equity | $51,904 | $61,529 | $66,322 | $12,236 | $18,086 |